Your browser doesn't support javascript.
loading
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.
Bardasi, Camilla; Spallanzani, Andrea; Benatti, Stefania; Spada, Francesca; Laffi, Alice; Antonuzzo, Lorenzo; Lavacchi, Daniele; Marconcini, Riccardo; Ferrari, Marco; Rimini, Margherita; Caputo, Francesco; Santini, Chiara; Cerma, Krisida; Casadei-Gardini, Andrea; Andrikou, Kalliopi; Salati, Massimiliano; Bertolini, Federica; Fontana, Annalisa; Dominici, Massimo; Luppi, Gabriele; Gelsomino, Fabio.
Affiliation
  • Bardasi C; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Spallanzani A; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Benatti S; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Spada F; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Laffi A; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Lavacchi D; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Marconcini R; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
  • Ferrari M; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Rimini M; Unit of Medical Oncology, Pisa University Hospital, Pisa, Italy.
  • Caputo F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Santini C; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Cerma K; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Casadei-Gardini A; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Andrikou K; Department of Medical Oncology, University Vita-Salute, San Raffaele Hospital, IRCCS, Milan, Italy.
  • Salati M; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Bertolini F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Fontana A; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Dominici M; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Luppi G; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
  • Gelsomino F; Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.
Endocrine ; 74(3): 707-713, 2021 12.
Article in En | MEDLINE | ID: mdl-34231124
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Carcinoma, Neuroendocrine Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Endocrine Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroendocrine Tumors / Carcinoma, Neuroendocrine Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Endocrine Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: